A kind of erlotinib-phthalocyanine conjugate and preparation method thereof
The technology of a conjugate and phthalocyanine is applied in the field of targeted anti-cancer molecule erlotinib phthalocyanine conjugate and its preparation, which can solve the problem of unsatisfactory tumor tissue targeting, difficulty in separation, difficulty in synthesis, etc. The problem is to achieve the effect of low cost, easy availability of raw materials and simple synthesis method.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0033] Embodiment 1 (M=Zn, m=3, R 1 =R 2 =-OCH 2 CH 2 OCH 3 , α single substitution)
[0034] 1) Add compound 10.5g (1.27mmol) and compound 20.68g (1.95mmol) into N,N-dimethylformamide (DMF), after both are dissolved, add K 2 CO 3 0.7g (5.07mmol), reacted at 50°C for 6h under the protection of nitrogen. After the reaction was finished, the DMF was spin-dried, and then the crude product was extracted with dichloromethane, followed by separation on a silica gel column with a dichloromethane-methanol volume ratio of 30:1 as the eluent to obtain 30.4 g of the compound. The yield was 55%. 1 HNMR (500MHz, CDCl 3 ): δ 8.41(s,1H,ArH),7.84(s,1H,ArH),7.45(s,1H,ArH),7.16(t, J =8.0Hz,1H,ArH),6.89(d, J =8.0Hz,1H,ArH),6.59(s,1H,ArH),6.41(d, J =8.0Hz,1H,ArH),4.49-4.45(m,4H,CH 2 ),4.40-4.38(m,4H,CH 2 ),3.80(t, J =4.5Hz,2H,CH 2 ),3.73(t, J =4.5Hz,4H,CH 2 ),3.67(t, J =4.5Hz,2H,CH 2 ),3.66-3.63(m,4H,CH 2 ),3.39-3.37(m,4H,CH 2 ),3.31(s,6H,CH 3 ),3.12(s,1H,CH),2.3(brs,1H,OH)...
Embodiment 2
[0037] Embodiment 2 (M=Al, m=6, R 1 =R 2 =-OCH 2 CH 2 OCH 3 , β single substitution)
[0038] 1) Add compound 10.5g (1.27mmol) and compound 20.68g (1.95mmol) into N,N-dimethylformamide (DMF), after both are dissolved, add K 2 CO 3 0.7g (5.07mmol), reacted at 50°C for 6h under the protection of nitrogen. After the reaction was finished, the DMF was spin-dried, and then the crude product was extracted with dichloromethane, followed by separation on a silica gel column with a dichloromethane-methanol volume ratio of 30:1 as the eluent to obtain 30.4 g of the compound. The yield was 55%. 1 HNMR (500MHz, CDCl 3 ): δ 8.36(s,1H,ArH),7.41(s,1H,ArH),7.24(s,1H,ArH),7.01(t, J =8.0Hz,1H,ArH),6.74(d, J =8.0Hz,1H,ArH),6.59(s,1H,ArH),6.41(d, J =8.0Hz,1H,ArH),4.32-4.29(m,4H,CH 2 ),4.26-4.22(m,4H,CH 2 ),3.70(t, J =4.5Hz,2H,CH 2 ),3.60(t, J=4.5Hz,4H,CH 2 ),3.56(t, J =4.5Hz,2H,CH 2 ),3.54-3.52(m,4H,CH 2 ),3.50-3.48(m,4H,CH 2 ),3.46-3.43(m,4H,CH 2 ),3.40-3.38(m,4H,CH 2 ),3...
Embodiment 3
[0041] Embodiment 3 (M=Si, m=8, R 1 =R 2 = H, α monosubstituted)
[0042] 1) Add compound 10.5g (1.27mmol) and compound 20.68g (1.95mmol) into N,N-dimethylformamide (DMF), after both are dissolved, add K 2 CO 3 0.7g (5.07mmol), reacted at 50°C for 6h under the protection of nitrogen. After the reaction was completed, the DMF was spin-dried, and then the crude product was extracted with dichloromethane, and then the volume ratio of dichloromethane-methanol was 30:1 as the eluent, and the compound 3 (0.4 g) was obtained by separation on a silica gel column. 1 HNMR (500MHz, CDCl 3 ): δ 8.49(s,1H,ArH),7.62(s,1H,ArH),7.36(s,1H,ArH),7.28(t, J =8.0Hz,1H,ArH),7.19(t, J =8.0Hz,1H,ArH),7.01(t, J =8.0Hz,1H,ArH),6.88(d, J =8.0Hz,1H,ArH),6.75(s,1H,ArH),6.55(d, J =8.0Hz,1H,ArH),4.89-4.86(m,4H,CH 2 ),4.78-4.75(m,4H,CH 2 ),3.92(t, J =4.5Hz,2H,CH 2 ),3.77(t, J =4.5Hz,4H,CH 2 ),3.64(t, J =4.5Hz,2H,CH 2 ),3.55-3.53(m,2H,CH 2 ),3.49-3.47(m,4H,CH 2 ),3.43-3.40(m,4H,CH 2 ),3.30...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com